Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2020 Filed Aug 5, 2020 21:41 UTC |
Zeldin Robert KChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $13.24 | $0.00 |
DisclosureSEC source: 0000899243-20-021492 · doc4.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires 2030-08-02 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on August 3, 2021 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| August 03, 2020 Filed Dec 21, 2020 22:08 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-012133 · edgar.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 864,518 F1 · kind: Gift to irrevocable trust. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:37 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 7,698 | $15.04 | $115,777.92 |
DisclosureSEC source: 0000899243-20-020052 · doc4.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,963 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.11, inclusive. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:39 UTC |
SHENK THOMAS EDirector
|
SaleOrdinary Shares | 6,667 | $15.00 | $100,005.00 |
DisclosureSEC source: 0000899243-20-020055 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 157,476 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · balance_after: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.025, inclusive. F3 · balance_after: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:37 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 2,356 | $15.00 | $35,340.00 |
DisclosureSEC source: 0000899243-20-020052 · doc4.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,661 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.02, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2020 Filed Nov 9, 2020 22:35 UTC |
Forbes AlexandriaDirector · President and CEO
|
GiftOrdinary Shares | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-010933 · edgar.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,415,781 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:57 UTC |
LEVINE ARNOLD JDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015260 · doc4.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 01:34 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPH10% owner
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015341 · doc4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Ellen Hukkelhoven in connection with her role as a member of the Issuer's Board of Directors. Ms. Hukkelhoven a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either F3 · ownership.nature: (continued from footnote 2) Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:04 UTC |
Mendoza NeilDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015271 · doc4.xml · derivative · entry 1 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:01 UTC |
MARCUS JOEL SDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015269 · doc4.xml · derivative · entry 1 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:01 UTC |
SHENK THOMAS EDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015268 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:01 UTC |
Indyk MartinDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015267 · doc4.xml · derivative · entry 1 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:57 UTC |
Hukkelhoven EllenDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015261 · doc4.xml · derivative · entry 1 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:56 UTC |
Harris Keith R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015257 · doc4.xml · derivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:55 UTC |
Seligman NicoleDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015255 · doc4.xml · derivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| May 22, 2020 Filed May 22, 2020 21:34 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 9,125 | $15.18 | $138,517.50 |
DisclosureSEC source: 0000899243-20-014040 · doc4.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.03 to $15.38, inclusive. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:44 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 11,786 | $15.16 | $178,675.76 |
DisclosureSEC source: 0000899243-20-014050 · doc4.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,064,518 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · balance_after: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · balance_after: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:34 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 14,732 | $15.18 | $223,631.76 |
DisclosureSEC source: 0000899243-20-014040 · doc4.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,427,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive. Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:44 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 6,143 | $15.03 | $92,329.29 |
DisclosureSEC source: 0000899243-20-014050 · doc4.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,076,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · balance_after: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.15, inclusive. F3 · balance_after: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:34 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 6,143 | $15.04 | $92,390.72 |
DisclosureSEC source: 0000899243-20-014040 · doc4.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441,938 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.15, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:10 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 71 | $15.38 | $1,091.98 |
DisclosureSEC source: 0000899243-20-013250 · doc4.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082,447 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · balance_after: On April 21, 2020, the reporting person transferred 85,000 shares to Aigle Healthcare Partners III LLC and now owns these shares indirectly through that entity. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:25 UTC |
MARCUS JOEL SDirector
|
SaleOrdinary Shares | 22 | $15.81 | $347.86 |
DisclosureSEC source: 0000899243-20-013106 · doc4.xml · nonDerivative · entry 2 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Third Amended and Restated Joel and Barbara Marcus Family Trust Disclosed balance after: 75,000 Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:25 UTC |
MARCUS JOEL SDirector
|
SaleOrdinary Shares | 4,900 | $15.77 | $77,273.00 |
DisclosureSEC source: 0000899243-20-013106 · doc4.xml · nonDerivative · entry 1 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Third Amended and Restated Joel and Barbara Marcus Family Trust Disclosed balance after: 75,022 Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:37 UTC |
SHENK THOMAS EDirector
|
SaleOrdinary Shares | 2,184 | $15.00 | $32,760.00 |
DisclosureSEC source: 0000899243-20-013012 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 164,143 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:36 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 11,304 | $15.39 | $173,968.56 |
DisclosureSEC source: 0000899243-20-013011 · doc4.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,017 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.77, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:02 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 696 | $15.00 | $10,440.00 |
DisclosureSEC source: 0000899243-20-011164 · doc4.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,321 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:00 UTC |
SHENK THOMAS EDirector
|
SaleOrdinary Shares | 4,482 | $15.00 | $67,230.00 |
DisclosureSEC source: 0000899243-20-011161 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 166,327 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| April 20, 2020 Filed May 15, 2020 21:10 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-013250 · doc4.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,518 Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 22:28 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 6,000 | $17.60 | $105,600.00 |
DisclosureSEC source: 0000899243-20-005320 · doc4.xml · nonDerivative · entry 3 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,017 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.36 to $18.05, inclusive. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:28 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 169 | $18.96 | $3,204.24 |
DisclosureSEC source: 0000899243-20-005320 · doc4.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,017 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.95 to $18.96, inclusive. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:28 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 5,831 | $18.30 | $106,707.30 |
DisclosureSEC source: 0000899243-20-005320 · doc4.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,186 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.93 to $18.88, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 29, 2020 Filed Jan 30, 2020 22:30 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 15,000 | $17.77 | $266,550.00 |
DisclosureSEC source: 0000899243-20-002360 · doc4.xml · nonDerivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.18 to $18.10, inclusive. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 22:30 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 139 | $17.91 | $2,489.49 |
DisclosureSEC source: 0000899243-20-002360 · doc4.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 22:30 UTC |
Forbes AlexandriaDirector · President & CEO
|
SaleOrdinary Shares | 14,861 | $17.35 | $257,838.35 |
DisclosureSEC source: 0000899243-20-002360 · doc4.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,220 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.72, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:42 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 9,000 | $19.34 | $174,060.00 |
DisclosureSEC source: 0000899243-20-001835 · doc4.xml · nonDerivative · entry 4 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,868 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.83 to $19.80, inclusive. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 502 | $20.32 | $10,200.64 |
DisclosureSEC source: 0000899243-20-001835 · doc4.xml · nonDerivative · entry 3 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,868 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.07 to $20.42, inclusive. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 8,498 | $19.51 | $165,795.98 |
DisclosureSEC source: 0000899243-20-001835 · doc4.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177,370 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.07 to $20.05, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:01 UTC |
Forbes AlexandriaDirector · President & CEO
|
GrantRestricted Share Units · Derivative | 195,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000984 · doc4.xml · derivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Ordinary Shares · 195,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:03 UTC |
Giroux RichardCFO & COO
|
GrantRestricted Share Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000986 · doc4.xml · derivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:00 UTC |
Naylor StuartChief Development Officer
|
GrantRestricted Share Units · Derivative | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000983 · doc4.xml · derivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Ordinary Shares · 160,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| December 27, 2019 Filed Jan 23, 2020 21:42 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-001835 · doc4.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185,868 Read SEC document |
| December 24, 2019 Filed Jan 30, 2020 22:30 UTC |
Forbes AlexandriaDirector · President & CEO
|
GiftOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002360 · doc4.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,478,081 Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:47 UTC |
Seligman NicoleDirector
|
PurchaseOrdinary Shares | 5,000 | $16.31 | $81,550.00 |
DisclosureSEC source: 0000899243-19-027695 · doc4.xml · nonDerivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported reflects the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $16.23 to $16.48, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 12, 2019 Filed Aug 20, 2019 22:00 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPH10% owner
|
PurchaseOrdinary Shares | 425,531 | $23.50 | $9,999,978.50 |
DisclosureSEC source: 0000899243-19-022128 · doc4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,433,277 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:18 UTC |
LEVINE ARNOLD JDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017805 · doc4.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 22:00 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPH10% owner
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017849 · doc4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Ellen Hukkelhoven in connection with her role as a member of the Issuer's Board of Directors. Ms. Hukkelhoven a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman is the managing member of the Advisor. F3 · ownership.nature: (continued from footnote 2) Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:18 UTC |
Mendoza NeilDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017807 · doc4.xml · derivative · entry 1 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:18 UTC |
Hukkelhoven EllenDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017806 · doc4.xml · derivative · entry 1 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:16 UTC |
SHENK THOMAS EDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017803 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:16 UTC |
Harris Keith R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017802 · doc4.xml · derivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.